Catheter Precision Inc (VTAK)
0.50
0.00 (0.00%)
USD |
NYAM |
May 31, 16:00
0.5122
+0.01
(+2.44%)
After-Hours: 20:00
Catheter Precision SG&A Expense (Annual): 17.12M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 17.12M |
December 31, 2022 | 16.25M |
December 31, 2021 | 15.48M |
December 31, 2020 | 24.53M |
Date | Value |
---|---|
December 31, 2019 | 51.55M |
December 31, 2018 | 30.44M |
December 31, 2017 | 14.95M |
December 31, 2016 | 5.321M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
15.48M
Minimum
2021
51.55M
Maximum
2019
24.99M
Average
17.12M
Median
2023
SG&A Expense (Annual) Benchmarks
Perspective Therapeutics Inc | 21.06M |
Retractable Technologies Inc | 20.01M |
InfuSystems Holdings Inc | 58.03M |
Xtant Medical Holdings Inc | 64.29M |
Asensus Surgical Inc | 36.08M |